# Session: sub_49c4f5c9:eu_ema

- **subagent_id**: `sub_49c4f5c9`
- **subagent_name**: `regulatory-reviewer`
- **session_id**: `eu_ema`
- **model_key**: `llm`
- **model_id**: `gemma-4-31b-it`
- **provider**: `openai_compat`
- **tools_granted**: `["Read", "Write", "Glob", "Grep"]`
- **accessible_paths**: `["/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations", "/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/protocols/v3_amendments.md", "/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/…[truncated 39 chars]`
- **context_size_max**: `21824`

## System Prompt

```
You are a medical affairs regulatory specialist reviewing clinical trial documents. Your task: read all three regulatory PDFs (cn_nmpa_2026.pdf, eu_ema_2026.pdf, us_fda_2026.pdf) in the regulations directory, and combine with the recruitment breakdown from the v3 amendments file. Produce a concise regulatory_map.md with: (1) study recruitment breakdown by country, (2) at least one key compliance requirement per country (CN, DE, US), citing exact section/clause numbers from the source PDFs. Output to notes/regulatory_map.md in the output directory. Be terse — plain bullets, no fluff.
```

## Timeline

## Turn 1 — user
Read the file regulations/eu_ema_2026.pdf. Extract at least one key compliance requirement relevant to a Phase II clinical trial, citing exact section/clause numbers. Be terse — just 2-3 bullet points with citations. Do NOT read the other PDFs.

> _system-reminder_: Context usage: 2212/100000 tokens (2%).

## Turn 2 — assistant
### Tool Call: `Read`
- **file_path**: `regulations/eu_ema_2026.pdf`

## Turn 3 — tool_result
_tool_call_id_: `chatcmpl-tool-a74ecb65b0eae52d`

tool error: file_path must be an absolute path; got 'regulations/eu_ema_2026.pdf'. Use a path under one of your accessible roots.

## Turn 4 — assistant
### Tool Call: `Glob`
- **pattern**: `**/regulations/eu_ema_2026.pdf`

## Turn 5 — tool_result
_tool_call_id_: `chatcmpl-tool-9708584081a16fa1`

(no matches)

## Turn 6 — assistant
### Tool Call: `Glob`
- **pattern**: `**/eu_ema_2026.pdf`

## Turn 7 — tool_result
_tool_call_id_: `chatcmpl-tool-a0fc81f70d2834b9`

/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf

## Turn 8 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`

## Turn 9 — tool_result
_tool_call_id_: `chatcmpl-tool-83321cf28295d0a0`

parsed text too large for a single Read: 650508 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 10 — assistant
### Tool Call: `Grep`
- **output_mode**: `content`
- **path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`
- **pattern**: `Phase II|compliance|requirement|Article|Section`

## Turn 11 — tool_result
_tool_call_id_: `chatcmpl-tool-991df9b60b089d99`

grep error: ripgrep (rg) is not installed

## Turn 12 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-qwen3.6-27b/run_local2_2780990/run_1780830995_516fc2/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`
- **limit**: `100`
- **offset**: `0`

## Turn 13 — tool_result
_tool_call_id_: `chatcmpl-tool-b91ce4ca361723a4`

1	--- Page 1 ---
2	European Medicines Agency (EMA)
3	Clinical Trials Guideline — EMA/CHMP/ICH/135/1995 (rev. 2026)
4	Incorporating ICH E6(R3) Good Clinical Practice
5	Effective: 2026-01-15
6	SECTION I — SCOPE AND PRINCIPLES
7	This guideline applies to all clinical trials submitted via CTIS under
8	R…[truncated 93258 chars]

## Turn 14 — assistant
**content**:

Key compliance requirements for Phase II clinical trial TR-2026-PHII-091 (compound-X42):

* **Record Retention:** Sponsors, investigators, and CROs must maintain complete records (pre-clinical, manufacturing, and clinical site documentation) for a minimum of 15 to 25 years following trial completion…[truncated 561 chars]
